What you'll learn
Vaccine safety data, policymaking, and science communication
- Sex and gender dimensions in COVID-19 vaccines, and its considerations in policy decision-making, and science communication for the public
- Lessons from past knowledge of sex-based differences in vaccine science and policy decision-making, including use of sex-disaggregated data and gender analysis in regulatory evaluations
- Current opportunities to respond to the biological differences in women and men in COVID-19 vaccine research and consequent deployment
- The path to ‘do better’ in addressing the sex and gender dimensions in vaccine and pharmaceutical R&D, policy-making and science communication process
Watch the webinar
Watch the webinar